{
  "resourceType": "ResearchStudy",
  "id": "16588",
  "meta": {
    "versionId": "4",
    "lastUpdated": "2020-05-18T01:05:12.069+00:00",
    "source": "#AnXF9ztCqz78qfFm",
    "tag": [
      {
        "system": "https://fhir.miracum.org/uc1/CodeSystem/registryStudyRole",
        "code": "master"
      }
    ]
  },
  "contained": [
    {
      "resourceType": "Group",
      "id": "1",
      "active": true,
      "type": "person",
      "actual": false,
      "name": "Eligibility criteria for the 'BYLIEVE' study.",
      "characteristic": [
        {
          "code": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
                "code": "age"
              }
            ]
          },
          "valueRange": {
            "low": {
              "value": 18,
              "system": "http://hl7.org/fhir/ValueSet/age-units",
              "code": "a"
            }
          },
          "exclude": false
        }
      ]
    }
  ],
  "extension": [
    {
      "url": "https://fhir.miracum.org/uc1/StructureDefinition/studyAcronym",
      "valueString": "BYLIEVE"
    }
  ],
  "identifier": [
    {
      "use": "official",
      "system": "http://www.clinicaltrialsregister.eu",
      "value": "2016-004586-67"
    },
    {
      "use": "usual",
      "system": "http://unklinikum-dresden.de/SponsorCode",
      "value": "D-V"
    },
    {
      "use": "secondary",
      "system": "https://fhir.uk-erlangen.de/NamingSystem/identifier/studyId",
      "value": "epjklerybqnr"
    },
    {
      "use": "usual",
      "system": "https://www.uniklinikum-dresden.de/de",
      "value": "900-000001299"
    },
    {
      "use": "official",
      "system": "http://clinicaltrials.gov",
      "value": "NCT03056755"
    }
  ],
  "title": "BYLieve: A phase II, multicenter, open-label, three-cohort,non-comparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole in patients with PIK3CA mutant, hormone receptor (HR) positive, HER2-negative advanced breast cancer (aBC), who have progressed on or after prior treatments",
  "status": "active",
  "condition": [
    {
      "coding": [
        {
          "system": "http://fhir.de/CodeSystem/dimdi/icd-10-gm",
          "code": "C50"
        }
      ],
      "text": "Bösartige Neubildung der Brustdrüse [Mamma]"
    }
  ],
  "relatedArtifact": [
    {
      "type": "documentation",
      "label": "2016-004586-67",
      "display": "EudraCT",
      "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-004586-67"
    },
    {
      "type": "documentation",
      "label": "NCT03056755",
      "display": "ClinicalTrials.gov",
      "url": "https://clinicaltrials.gov/ct2/show/study/NCT03056755"
    }
  ],
  "keyword": [
    {
      "coding": [
        {
          "system": "https://fhir.uk-erlangen.de/CodeSystem/studyCategory",
          "code": "entgyn"
        }
      ],
      "text": "Gynäkologische Tumore (z.B. Brustkrebs, Gebärmutterkrebs)"
    },
    {
      "coding": [
        {
          "system": "https://fhir.uk-erlangen.de/CodeSystem/studyCategory",
          "code": "gynmamma"
        }
      ],
      "text": "Brustkrebs (Mammakarzinom)"
    }
  ],
  "description": "Eine multizentrische, offene, nicht-vergleichende Phase II-Studie mit zwei Kohorten zur Untersuchung der Wirksamkeit und Sicherheit von Alpelisib plus Fulvestrant oder Letrozol bei Patienten mit PIK3CA-mutierten, Hormonrezeptor positiven (HR+), HER2 negativen (HER2-) fortgeschrittenen Brustkrebs (aBC), die unter oder nach einer Therapie mit einem CDK4/6-Inhibitor einen Progress erlitten haben.",
  "enrollment": [
    {
      "reference": "#1"
    }
  ],
  "site": [
    {
      "extension": [
        {
          "url": "https://fhir.miracum.org/uc1/StructureDefinition/siteRecruitmentStatus",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "http://hl7.org/fhir/research-study-status",
                "code": "active"
              }
            ]
          }
        },
        {
          "url": "https://fhir.miracum.org/uc1/StructureDefinition/siteContact",
          "valueContactDetail": {
            "name": "Studienzentrum Frauenklinik",
            "telecom": [
              {
                "system": "email",
                "value": "fk-studienzentrale@<REDACTED>",
                "use": "work",
                "rank": 1
              },
              {
                "system": "phone",
                "value": "+49 9131-<REDACTED>",
                "use": "work",
                "rank": 1
              }
            ]
          }
        }
      ],
      "reference": "Location/1"
    },
    {
      "extension": [
        {
          "url": "https://fhir.miracum.org/uc1/StructureDefinition/siteRecruitmentStatus",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "http://hl7.org/fhir/research-study-status",
                "code": "active"
              }
            ]
          }
        },
        {
          "url": "https://fhir.miracum.org/uc1/StructureDefinition/siteContact",
          "valueContactDetail": {
            "name": "C <REDACTED>",
            "telecom": [
              {
                "system": "email",
                "value": "studiensekretariat.gyn@<REDACTED>",
                "use": "work",
                "rank": 1
              },
              {
                "system": "phone",
                "value": "+49 351-<REDACTED>",
                "use": "work",
                "rank": 1
              }
            ]
          }
        },
        {
          "url": "https://fhir.miracum.org/uc1/StructureDefinition/siteContact",
          "valueContactDetail": {
            "name": "Dr. <REDACTED>",
            "telecom": [
              {
                "system": "email",
                "value": "<REDACTED>",
                "use": "work",
                "rank": 1
              }
            ]
          }
        },
        {
          "url": "https://fhir.miracum.org/uc1/StructureDefinition/siteContact",
          "valueContactDetail": {
            "name": "Prof. Dr. med. <REDACTED>",
            "telecom": [
              {
                "system": "email",
                "value": "<REDACTED>",
                "use": "work",
                "rank": 1
              }
            ]
          }
        }
      ],
      "reference": "Location/8892"
    }
  ]
}